Reference | Country, years | N | Urinary phthalate metabolites | Timing of urine collection | in utero outcome(s) | Timing of outcome assessment | Notes1 | All2 | Girls2 | Boys2 |
---|---|---|---|---|---|---|---|---|---|---|
Zhao et al. 2014 [97] | China 2012-2013 | 126 | MBP, MMP ∑DEHP: MEHP, MEHHP, MEOHP | 3rd trimester | IUGR | 3rd trimester | + IUGR (MEHHP) | |||
Zhao et al. 2015 [126] | China 2011-2013 | 119 | MBP, MMP ∑DEHP: MEHP, MEHHP, MEOHP | 3rd trimester | Growth restricted (IUGR or low birth weight) | not specified | + Growth restricted (MEHP, MEHHP, MEOHP, ∑DEHP) | |||
<37 weeks only | NS | |||||||||
≥37 weeks only | + Growth restricted (MEHHP, MEOHP, ∑DEHP) | |||||||||
Botton et al. 2016 [99] | France 2003-2006 | 520 | ∑LMW: MEP, MBP, MiBP ∑HMW: MBzP, MCOP, MCPP, MCNP, MECPP, MEHHP, MEOHP, MEHP ∑DEHP: MECPP, MEHHP, MEOHP, MEHP | 26 weeks | EFW AC BPD HC FL | 12 weeks | ̵ BPD (MBzP, ∑HMW, MECPP, MEHHP, MEOHP, ∑DEHP) | |||
22 weeks | - EFW (MBzP, MCNP) - BPD (MBzP, MCPP, ∑HMW, MECPP, MEHHP, MEOHP, MEHP, ∑DEHP) + FL (MCNP) | |||||||||
32 weeks | - BPD (MCPP, ∑HMW, MECPP, MEHHP, MEOHP, MEHP, ∑DEHP) + FL (MCNP) | |||||||||
overall pregnancy | - EFW (∑HMW, MECPP, MEHHP) - BPD (MBzP, ∑HMW, MECPP, MEOHP, ∑DEHP) + FL (MCNP) | |||||||||
Casas et al. 2016 [100] | Spain 2004-2006 | 390 | MBzP ∑LMW: MEP, MiBP, MnBP; ∑DEHP: MEHP, MEHHP, MEOHP, MECPP | 12, 32 weeks** | EFW AC BPD HC FL | 12 weeks | not adjusted for GA | NS | NS | NS |
20 weeks | - HC (MnBP) | NS | NS | |||||||
34 weeks | + FL (MBzP) | + FL (MBzP) | NS | |||||||
growth rate 12-20 weeks | - EFW (MnBP) - HC (MnBP) | - HC (MnBP) | - HC (MnBP) | |||||||
growth rate 20-34 weeks | + FL (MBzP) | + FL (MBzP) | + EFW (MnBP) + AC (MnBP) | |||||||
USA 2006-2008 | 482 | MEP, MBP, MiBP, MBzP, MCPP ∑DEHP: MECPP, MEHHP, MEOHP, MEHP | 10, 18, 26, 35 weeks** | EFW AC HC FL | 26, 35, 38 weeks | - EFW (MEOHP, MECPP, ∑DEHP) - AC (MECPP, ∑DEHP) - HC (MECPP, MBzP) - FL (MECPP, ∑DEHP) | - EFW (MECPP, ∑DEHP) - HC (MEP) | - AC (∑DEHP) - FL (MEHHP, MEOHP, ∑DEHP) |